Cargando…
Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
Severe respiratory viral infections, such as influenza, metapneumovirus (HMPV), respiratory syncytial virus (RSV), rhinovirus (RV), and coronaviruses, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), cause significant mortality and morbidity worldwide. These viruses have been...
Autores principales: | Lukacs, Nicholas W., Malinczak, Carrie-Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766447/ https://www.ncbi.nlm.nih.gov/pubmed/33371275 http://dx.doi.org/10.3390/vaccines8040783 |
Ejemplares similares
-
Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases
por: Malinczak, Carrie-Anne, et al.
Publicado: (2020) -
Role of ILC2 in Viral-Induced Lung Pathogenesis
por: Fonseca, Wendy, et al.
Publicado: (2021) -
NLRP3-Inflammasome Inhibition during Respiratory Virus Infection Abrogates Lung Immunopathology and Long-Term Airway Disease Development
por: Malinczak, Carrie-Anne, et al.
Publicado: (2021) -
Uric acid pathway activation during Respiratory virus infection promotes Th2 immune responses via innate cytokine production and ILC2 accumulation
por: Fonseca, Wendy, et al.
Publicado: (2020) -
Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease
por: Malinczak, Carrie-Anne, et al.
Publicado: (2019)